Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tapeworms are parasitic flatworms that inhabit the intestines of vertebrate hosts. They have a segmented body composed of a scolex for attachment, a neck for segment generation, and a strobila consisting of proglottids. They have complex life cycles involving intermediate hosts where larvae develop into cysticerci. Humans become infected by ingesting undercooked meat/fish containing cysticerci. Infections can cause abdominal pain, diarrhea, nausea, and weight loss. In rare cases, larval migration can lead to serious complications. Diagnosis is often made by observing proglottids in stool. Treatment involves antiparasitic medications like praziquantel.
Praziquantel: antiparasitic medication that damages the parasite's tegument, leading to paralysis and death.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tapeworms.